2074
S.-Y. ZHAO ET AL.
REFERENCES
1. (a) Tang, Y. M.; Li, J.; Zhao, S. Y. Progress in the study of 4-hydroxy-2-pyridone natural
alkaloids. Chin. J. Org. Chem. 2011, 31, 9–21; (b) Jessen, H. J.; Gademann, K.
4-Hydroxy-2-pyridone alkaloids: Structures and synthetic approaches. Nat. Prod. Rep.
2010, 27, 1168–1185.
2. (a) Hayakawa, S.; Minato, H.; Katagiri, K. The ilicicolins, antibiotics from
Cylindrocladium ilicicola. J. Antibiot. 1971, 24, 653–654.
3. Matsumoto, M.; Minato, H. Structure of ilicocolin H, an antifungal antibiotic.
Tetrahedron Lett. 1976, 17, 3827–3830.
4. (a) Gutierrez-Cirlos, E. B.; Merbitz-Zahradnik, T.; Trumpower, B. L. Inhibition of the
yeast cytochrome bc1 complex by Ilicicolin H, a novel inhibitor that acts at the Qn site
of the bc1 complex. J. Biol. Chem. 2004, 279, 8708–8714; (b) Rotsaert, F. A. J.; Ding,
M. G.; Trumpower, B. L. Differential efficacy of inhibition of mitochondrial and bacterial
cytochrome bc1 complexes by center N inhibitors antimycin, Ilicicolin H, and funiculosin.
BBA-Bioenergetics 2008, 1777, 211–219; (c) Covian, R.; Trumpower, B. L. Ilicicolin
inhibition and binding at center N of the dimeric cytochrome bc1 complex reveal electron
transfer and regulatory interactions between monomers. J. Biol. Chem. 2009, 284,
8614–8620.
5. Liu, W.; Guan, Z.; Singh, S. B. A new method for the synthesis of 1,4,5-oxadiazocines and
its application in the structure modification of natural products. Tetrahedron Lett. 2005,
46, 8009–8012.
6. Singh, S. B.; Li, X. H.; Chen, T. Biotransformation of antifungal ilicicolin H. Tetrahedron
Lett. 2011, 52, 6190–6191.
7. Singh, S. B.; Liu, W.; Li, X.; Chen, T.; Shafiee, A.; Card, D.; Abruzzo, G.; Flattery, A.;
Gill, C.; Thompson, J. R.; Rosenbach, M.; Dreikorn, S.; Hornak, V.; Meinz, M.; Kurtz,
M.; Kelly, R.; Onishi, J. C. Antifungal spectrum, in vivo efficacy, and structure–activity
relationship of Ilicicolin H. ACS Med. Chem. Lett. 2012, 3, 814–817.
8. Singh, S. B.; Liu, W.; Li, X.; Chen, T.; Shafiee, A.; Dreikorn, S.; Hornak, V.; Meinz, M.;
Onishi, J. C. Structure–activity relationship of cytochrome bc1 reductase inhibitor broad
spectrum antifungal Ilicicolin H. Bioorg. Med. Chem. Lett. 2013, 23, 3018–3022.
9. (a) Zhao, S. Y.; Huang, J.; Cheng, J.; Liu, B. S.; Chen, C. Progress in the synthesis of
4-hydroxy-2-pyridone derivatives. Chin. J. Org. Chem. 2012, 32, 651–660; (b) Li, J.; Zhao,
S. Y. Synthesis of N-methyl-4-hydroxy-5-phenyl-2-pyridone. Chin. J. Synth. Chem. 2012,
20, 740–741.
10. (a) Rigby, J. H.; Burkhardt, F. J. Vinyl isocyanates as aza diene equivalents: A method for
the synthesis of functionalized 4-hydroxy-2(1H)-pyridones. J. Org. Chem. 1986, 51,
1374–1376; (b) Rigby, J. H.; Qabar, M. Convergent total synthesis of (þ)-tenellin. J.
Org. Chem. 1989, 54, 5852–5853.
11. (a) Miyagawa, T.; Nagai, K.; Yamada, A.; Sugihara, Y.; Fukuda, T.; Uchida, R.;
Tomoda, H.; Omura, S.; Nagamitsu, T. Total synthesis of Citridone A. Org. Lett.
2011, 13, 1158–1161; (b) Zhang, Q.; Rivkin, A.; Curran, D. P. Quasiracemic synthesis:
Concepts and implementation with a fluorous tagging strategy to make both enantiomers
of pyridovericin and mappicine. J. Am. Chem. Soc. 2002, 124, 5774–5781.
12. (a) Jones, R. C. F.; Choudhury, A. K.; Iley, J. N.; Loizou, G.; Lumley, C.; McKee, V.
New methodologies for the synthesis of 3-acylpyridone metabolites. Synlett 2010,
654–658; (b) Jones, R. C. F.; Bhalay, G.; Carter, P. A.; Duller, K. A. M.; Dunn, S. H.
1,3-Dipolar cycloaddition route to nitrogen heterocyclic triones. J. Chem. Soc., Perkin
Trans. 1 1999, 765–776; (c) Jones, R. C. F.; Bhalay, G.; Carter, P. A.; Duller, K. A.
M.; Vulto, S. I. E. A 1,3-dipolar cycloaddition route to 3-acyl-4-hydroxypyridin-2-ones
and pyran-2-ones. Synlett 1995, 149–150.